Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,571,916,998
+$418,575,548 QoQ
Shares Held
15,836,058
+0.6% QoQ
Ownership
2.93%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 46.15891151699495.ToString("F0")%
Shared 0.ToString("F0")%
None 53.84108848300505.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. AMGN ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
This page
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,571,916,998 | 15,836,058 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,153,341,450 | 15,744,528 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,489,950,149 | 15,910,525 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $4,518,952,693 | 16,184,781 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,057,740,388 | 16,234,121 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,794,819,868 | 14,559,622 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $4,734,625,263 | 14,694,222 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,487,556,242 | 14,362,478 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $3,972,508,509 | 13,971,963 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $4,157,298,529 | 14,434,062 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $3,560,525,216 | 13,247,973 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $3,019,469,549 | 13,599,989 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,097,010,168 | 12,810,797 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,493,470,496 | 13,301,365 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,654,693,574 | 11,777,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,435,389,669 | 14,119,974 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,489,007,729 | 14,428,119 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,173,429,089 | 9,660,973 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,106,690,582 | 9,906,845 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,447,477,169 | 10,040,932 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,478,150,082 | 9,960,010 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,240,698,232 | 9,745,556 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,177,106,852 | 8,565,891 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,887,964,478 | 8,004,598 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,472,597,264 | 7,263,835 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||